Severity of deliberate acute baclofen poisoning: A nonconcurrent cohort study

Basic and Clinical Pharmacology and Toxicology

Volumn 114, Issue 4, 2014, Pages 360-364

  Pommier, Philippe ^a   Debaty, Guillaume ^a,b   Bartoli, Mireille ^a   Viglino, Damien ^a   Carpentier, Françoise ^a   Danel, Vincent ^a   Maxime, Maignan ^a,b  

^a HÔPITAL MICHALLON   (France)

^b LABORATOIRE TIMC IMAG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BACLOFEN; BENZODIAZEPINE DERIVATIVE; MEPROBAMATE; NEUROLEPTIC AGENT; OPIATE; PARACETAMOL;

ADULT; ALCOHOL CONSUMPTION; ARTERIAL OXYGEN SATURATION; ARTICLE; ARTIFICIAL VENTILATION; ASPIRATION PNEUMONIA; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CONVULSION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG INTOXICATION; DRUG MEGADOSE; DRUG OVERDOSE; DRUG SAFETY; EMERGENCY PHYSICIAN; FEMALE; GLASGOW COMA SCALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SELF POISONING; SYSTOLIC BLOOD PRESSURE; VITAL SIGN;

ADULT; ALCOHOLISM; BACLOFEN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG OVERDOSE; ENDPOINT DETERMINATION; FEMALE; HUMANS; INTENSIVE CARE UNITS; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEIZURES; TREATMENT OUTCOME;

EID: 84895425087     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/bcpt.12161     Document Type: Article

References (39)

1. Aubin HJ, Daeppen JB. Emerging pharmacotherapies for alcohol dependence: a systematic review focusing on reduction in consumption. Drug Alcohol Depend 2013;133:15-29.
2. Gorsane MA, Kebir O, Hache G, Blecha L, Aubin HJ, Reynaud M et al. Is Baclofen a Revolutionary Medication in Alcohol Addiction Management? Review and Recent Updates. Subst Abus 2012;33:336-49.
3. Tyacke RJ, Lingford-Hughes A, Reed LJ, Nutt DJ. GABAB receptors in addiction and its treatment. Adv Pharmacol 2010;58:373-96.
4. Addolorato G, Caputo F, Capristo E, Domenicali M, Bernardi M, Janiri L et al. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. Alcohol Alcohol 2002;37:504-8.
5. Addolorato G, Leggio L, Abenavoli L, Agabio R, Caputo F, Capristo E et al. Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam. Am J Med 2006;119:276.e13-8.
6. Addolorato G, Leggio L, Ferrulli A, Cardone S, Bedogni G, Caputo F et al. Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial. Alcohol Alcohol 2011;46:312-7.
7. Flannery BA, Garbutt JC, Cody MW, Renn W, Grace K, Osborne M et al. Baclofen for alcohol dependence: a preliminary open-label study. Alcohol Clin Exp Res 2004;28:1517-23.
8. Garbutt JC, Kampov-Polevoy AB, Gallop R, Kalka-Juhl L, Flannery BA. Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial. Alcohol Clin Exp Res 2010;34:1849-57.
9. Leggio L, Ferrulli A, Zambon A, Caputo F, Kenna GA, Swift RM et al. Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infection. Addict Behav 2012;37:561-4.
10. Rigal L, Alexandre-Dubroeucq C, de Beaurepaire R, Le Jeunne C, Jaury P. Abstinence and "low-risk" consumption 1 year after the initiation of high-dose baclofen: a retrospective study among "high-risk" drinkers. Alcohol Alcohol 2012;47:439-42.
11. Maccioni P, Bienkowski P, Carai MAM, Gessa GL, Colombo G. Baclofen attenuates cue-induced reinstatement of alcohol-seeking behavior in Sardinian alcohol-preferring (sP) rats. Drug Alcohol Depend 2008;95:284-7.
12. Maccioni P, Colombo G. Role of the GABAB receptor in alcohol-seeking and drinking behavior. Alcohol 2009;43:555-8.
13. Quintanilla ME, Perez E, Tampier L. Baclofen reduces ethanol intake in high-alcohol-drinking University of Chile bibulous rats. Addict Biol 2008;13:326-36.
14. De Beaurepaire R. Suppression of Alcohol Dependence Using Baclofen: a 2-Year Observational Study of 100 Patients. Front Psychiatry 2012;3:103.
15. Leung NY, Whyte IM, Isbister GK. Baclofen overdose: defining the spectrum of toxicity. Emerg Med Australas 2006;18:77-82.
16. Weißhaar GF, Hoemberg M, Bender K, Bangen U, Herkenrath P, Eifinger F et al. Baclofen intoxication: a "fun drug" causing deep coma and nonconvulsive status epilepticus-a case report and review of the literature. Eur J Pediatr 2012;171:1541-7.
17. Bronstein AC, Spyker DA, Cantilena LR Jr, Rumack BH, Dart RC. 2011 annual report of the american association of poison control centers' national poison data system: 29th annual report. Clin Toxicol 2012;50:911-1164.
18. Bohnert ASB, Roeder K, Ilgen MA. Unintentional overdose and suicide among substance users: a review of overlap and risk factors. Drug Alcohol Depend 2010;110:183-92.
19. Saviuc P, Garnier R, Bidault I, Manel J. Baclofen and alcohol dependence: a treatment at risk? EAPCCT congress London 2012. Clin Toxicol 2012;50:350.
20. Maignan M, Pommier P, Clot S, Saviuc P, Debaty G, Briot R et al. Deliberate medicine-poisoning with slight symptoms on admission: are there predictive factors for intensive care unit referral? A three-year retrospective study. Basic Clin Pharmacol Toxicol 2012;doi: 10.1111/bcpt.12132.
21. Owens WD, Felts JA, Spitznagel EL Jr. ASA physical status classifications: a study of consistency of ratings. Anesthesiology 1978;49:239-43.
22. Christ A, Arranto CA, Schindler C, Klima T, Hunziker PR, Siegemund M et al. Incidence, risk factors, and outcome of aspiration pneumonitis in ICU overdose patients. Intensive Care Med 2006;32:1423-7.
23. Isbister GK, Downes F, Sibbritt D, Dawson AH, Whyte IM. Aspiration pneumonitis in an overdose population: frequency, predictors, and outcomes. Crit Care Med 2004;32:88-93.
24. Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 2001;344:665-71.
25. Goda R, Murayama N, Fujimaki Y, Sudo K. Simple and sensitive liquid chromatography-tandem mass spectrometry method for determination of the S(+)- and R(-)-enantiomers of baclofen in human plasma and cerebrospinal fluid. J Chromatogr B Analyt Technol Biomed Life Sci 2004;801:257-64.
26. Novack V, Jotkowitz A, Delgado J, Novack L, Elbaz G, Shleyfer E et al. General characteristics of hospitalized patients after deliberate self-poisoning and risk factors for intensive care admission. Eur J Intern Med 2006;17:485-9.
27. http://www.openepi.com/v37/Menu/OE_Menu.htm/ (last accessed on 23 August 2013).
28. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007;335:806-8.
29. Hoppe-Roberts JM, Lloyd LM, Chyka PA. Poisoning mortality in the United States: comparison of national mortality statistics and poison control center reports. Ann Emerg Med 2000;35:440-8.
30. Lam S-M, Lau AC-W, Yan W-W. Over 8 years experience on severe acute poisoning requiring intensive care in Hong Kong, China. Hum Exp Toxicol 2010;29:757-65.
31. Sein AnandJ, Chodorowski Z, Burda P. Selected clinical aspects of acute intoxication with baclofen. Przegl Lek 2005;62:462-4.
32. Flensborg-Madsen T, Knop J, Mortensen EL, Becker U, Sher L, Grønbaek M. Alcohol use disorders increase the risk of completed suicide-irrespective of other psychiatric disorders. A longitudinal cohort study. Psychiatry Res 2009;167:123-30.
33. Kessler RC, Borges G, Walters EE. Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey. Arch Gen Psychiatry 1999;56:617-26.
34. Cruz HG, Ivanova T, Lunn M-L, Stoffel M, Slesinger PA, Lüscher C. Bi-directional effects of GABA(B) receptor agonists on the mesolimbic dopamine system. Nat Neurosci 2004;7:153-9.
35. Terrier J, Ort A, Yvon C, Saj A, Vuilleumier P, Lüscher C. Bi-directional effect of increasing doses of baclofen on reinforcement learning. Front Behav Neurosci 2011;5:40.
36. Takahashi A, Schilit AN, Kim J, Debold JF, Koide T, Miczek KA. Behavioral characterization of escalated aggression induced by GABA(B) receptor activation in the dorsal raphe nucleus. Psychopharmacology 2012;224:155-66.
37. Brown HD, Baker PM, Ragozzino ME. The parafascicular thalamic nucleus concomitantly influences behavioral flexibility and dorsomedial striatal acetylcholine output in rats. J Neurosci 2010;30:14390-8.
38. Kupper LL, Karon JM, Kleinbaum DG, Morgenstern H, Lewis DK. Matching in epidemiologic studies: validity and efficiency considerations. Biometrics 1981;37:271-91.
39. Grimes DA, Schultz KF. Cohort studies: marching towards outcomes. Lancet 2002;359:341-5.